NSE › Healthcare

Caplin Point Laboratories Limited (CAPLIPOINT)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,566.10+1.96%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹600 cr
Revenue YoY
+18.9%
Net profit
₹170 cr
Profit YoY
+19.3%
EPS
₹13.34
Net margin
28.3%

Key statistics

Market cap
₹19,056 cr
P/E
29.8
Forward P/E
0.0
P/B
5.33
Book value
₹462.02
EPS (TTM)
₹84.06
52-week high
₹2,699.00
52-week low
₹1,497.33
50-day MA
₹2,412.73
200-day MA
₹1,959.78
Beta
0.19

Analyst view

with an average price target of ₹2,505.00.

Shareholding

Promoters
73.61%
Institutions
5.58%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Caplin Point Laboratories Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.